Efficacy of ezetimibe for the treatment of non-alcoholic steatohepatitis: an open-label, pilot study
Available from: Bertoccini L, Baroni MG (2021) GLP-1 receptor agonists and SGLT2 inhibitors for the treatment of type 2 diabetes: new insights and opportunities for cardiovascular protection
Omada will use clinical eligibility, health metrics and behavioral data gleaned from care it has already provided to its GLP-1 care track patients to guide prescribing decisions and care plans
In recent research, ginger, and its active compound gingerol, have shown potential in modulating GLP-1 activity, improving insulin response and managing blood glucose through a variety of pathways
[DOI] [PMC free article] [PubMed] [Google Scholar] 807.Kim H.J., So H.S., Lee J.H., Park C., Lee J.B., Youn M.J., Kim S.J., Yang S.H., Lee K.M., Kwon K.B., et al